Inventor · disambiguated record
Mark Froimowitz
Also filed as: FROIMOWITZ MARK
9 granted patents·4 pending applications·116 citations·filing 1993–2006
86Inventor score
Files withALLELIX PHARM ECO L P2BIOFRONTERA BIOSCIENCE GMBH2CHILDRENS MEDICAL CENTER2RHODE ISLAND EDUCATION2FROIMOWITZ MARK1
Top patents by PatentIndex Score
13 records- 0188US7060711B2Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonistBIOFRONTERA BIOSCIENCE GMBH·Filed 2002·Granted Jun 13, 2006·24 cites·10 claims
- 0285US6028103ATriaryl methane compounds and analogues thereof useful for the treatment or prevention of sickle cell disease or diseases characterized by abnormal cell proliferationCHILDRENS MEDICAL CENTER·Filed 1997·Granted Feb 22, 2000·36 cites·42 claims
- 0375US6331564B1Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory diseaseION PHARMACEUTICALS INC·Filed 1998·Granted Dec 18, 2001·43 cites·13 claims
- 0456US7511064B2Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonistBIOFRONTERA BIOSCIENCE GMBH·Filed 2006·Granted Mar 31, 2009·0 cites·21 claims
- 0552US2002119953A1Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory diseaseFiled 2001·Application pending·0 cites
- 0644US6011070ASlow-onset, long-lasting dopamine reuptake blockersALLELIX PHARM ECO L P·Filed 1997·Granted Jan 4, 2000·10 cites·27 claims
- 0742US7531573B2Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory diseaseCHILDRENS MEDICAL CENTER·Filed 2003·Granted May 12, 2009·0 cites·11 claims
- 0838US2006100243A1Methylphenidate analogs and methods of use thereofFROIMOWITZ MARK·Filed 2005·Application pending·0 cites
- 0937US6262064B1Octahydrobenzo[f]quinoline-based receptor agonists and antagonistsRHODE ISLAND EDUCATION·Filed 1999·Granted Jul 17, 2001·1 cites·6 claims
- 1037US2003022920A11-Methyl-4- (3-ethoxy-9H-thioxanthene-9-ylidene) -piperidine and its use as 5-HT2B/H1 receptor antagonistFiled 2002·Application pending·0 cites
- 1134US5821386ACompounds for treating cocaine abuseALLELIX PHARM ECO L P·Filed 1997·Granted Oct 13, 1998·2 cites·8 claims
- 1228US5863928AOctahydrobenzo f!quinoline-based receptor agonists and antagonistsRHODE ISLAND EDUCATION·Filed 1993·Granted Jan 26, 1999·0 cites·11 claims
- 1327US2003134842A1Methods for the treatment or prevention of inflammatory diseases characterized by abnormal cell proliferationFiled 1998·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →